Toripalimab in Combination With Chemotherapy and Antiangiogenic Agents in Patients With Non-Small Cell Lung Cancer After Failure of Immunotherapy (PD-1/L1 Inhibitors)

Name: Toripalimab in Combination With Chemotherapy and Antiangiogenic Agents in Patients With Non-Small Cell Lung Cancer After Failure of Immunotherapy (PD-1/L1 Inhibitors)
Published: 2023
License: Public Domain

Tianjin Medical University Cancer Institute and Hospital · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

non small cell lung cancer recurrent, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Toripalimab in Combination With Chemotherapy and Antiangiogenic Agents in Patients With Non-Small Cell Lung Cancer After Failure of Immunotherapy (PD-1/L1 Inhibitors)

Related documents